Data Protection Strategy for Rapidly Growing Life Sciences Company Post-Launch of Its First Product

Triverus led the assessment of the client’s information exposure and recommended an actionable set of initiatives to address the information protection needs of the client’s growing business.


With their first therapy approved and several promising drugs in various stages of development, the client was experiencing a steep growth trajectory.  The company’s data environment was also growing exponentially in size and complexity.  Like many organizations transitioning from clinical to commercial, this client required assistance to address the risks associated with Data Liability caused by this rapid growth.


Triverus worked closely with business and IT stakeholders to define desired practices, assess and prioritize gaps and define initiatives to address each gap.  Triverus established a Risk Index that quantifies the potential impact of a vulnerability and supports prioritization.  Out of over 100 issues identified, Triverus worked with the client’s business stakeholders to prioritize the most critical issues and plan for immediate remediation.  High and moderate risk issues were scheduled to be addressed immediately after the initial critical issues.  The client now has a comprehensive understanding of its data liability risks and an actionable roadmap on how to address them. Triverus is actively engaged in implementing many of the recommendations.

How We Helped

Triverus’ disciplined process and proven methodology provided the structure necessary to attack this complicated problem.  Our partnering approach ensured the results leveraged industry best practices while simultaneously adapting the recommendations to the client’s unique business needs.  

Life Sciences
Data Liability Protection
Commercial IT Readiness​
Related Case Studies
Inventory Valuation for Life Sciences Company
Life Sciences Information Management Data Flows and Inventory